SAN FRANCISCO — A Medtronic implantable heart valve may be “safer” and present a “lower risk of death,” but Medtronic is willfully infringing a competitor’s version and therefore is being ordered off the market by a Delaware federal judge.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to email@example.com to learn more.